| Literature DB >> 26672873 |
Shintaro Sasaki1, Tetsu Watanabe1, Harutoshi Tamura1, Satoshi Nishiyama1, Masahiro Wanezaki1, Chika Sato1, Gensai Yamaura1, Mitsunori Ishino1, Takanori Arimoto1, Hiroki Takahashi1, Tetsuro Shishido1, Takuya Miyamoto1, Isao Kubota1.
Abstract
BACKGROUND: Left atrial appendage (LAA) dysfunction predisposes patients with atrial fibrillation (AF) to cardioembolic stroke. Two-dimensional (2D) speckle tracking was reported to be useful for evaluating left atrial (LA) regional function, as well as left ventricular function. However, it remains unclear whether 2D speckle tracking is useful for evaluating LAA dysfunction. Therefore, we investigated whether decreased LA strain may predict LAA dysfunction and thrombus formation in patients with acute ischemic stroke.Entities:
Keywords: 2D speckle tracking; Ischemic stroke; Left atrial appendage function; Left atrial dysfunction; Non-invasive
Year: 2014 PMID: 26672873 PMCID: PMC4633975 DOI: 10.1016/j.bbacli.2014.09.004
Source DB: PubMed Journal: BBA Clin ISSN: 2214-6474
Fig. 1Measurement of LA peak systolic strain. LA strain was estimated by averaging the longitudinal strain data obtained from the apical four-chamber, two-chamber and apical long-axis views. The LA myocardium was divided into five regions of equal area. Five segments were analyzed from the apical four- and two-chamber views, whereas only three segments were analyzed in the apical long axis view. LA, left atrium. We show good LA strain with sinus rhythm in Fig. 1B and bad LA strain with atrial fibrillation (Fig. 1C).
Clinical characteristics of all patients.
| Number of patients | 120 |
|---|---|
| Age, years | 72 ± 11 |
| Gender (M/F) | 83/37 |
| Atrial fibrillation, n (%) | 74 (62) |
| Paroxysmal AF, n | 36 |
| Chronic AF, n | 38 |
| Hypertension, n (%) | 88 (73) |
| Diabetes mellitus, n (%) | 35 (29) |
| Dyslipidemia, n (%) | 58 (48) |
| Smokers, n (%) | 64 (53) |
| Chronic heart failure, n (%) | 35 (29) |
| Previous stroke, n (%) | 28 (23) |
| CHA2DS2VASc score | 3.7 ± 1.8 |
| NIHSS | 1.0 (0.5–3.0) |
| Medications | |
| Antiplatelet drugs, n (%) | 42 (35) |
| Anticoagulants, n (%) | 54 (45) |
| Warfarin, n | 46 |
| Dabigatran, n | 8 |
| NINDS clinical categories | |
| Cardioembolic stroke, n (%) | 53 (44) |
| Atherothrombotic stroke, n (%) | 20 (17) |
| Lacunar stroke, n (%) | 14 (12) |
| Other or undetermined, n (%) | 33 (28) |
AF, atrial fibrillation; NIHSS, National Institute of Health Stroke Scale.
Data are expressed as mean ± SD, number (percentage) of subjects or median (interquartile range).
CHA2DS2VASc score before onset of acute ischemic stroke.
Comparison of the characteristics of stroke patients with or without LAA dysfunction.
| Normal LAA function | LAA dysfunction | ||
|---|---|---|---|
| (n = 72) | (n = 48) | ||
| Age (years) | 70 ± 11 | 77 ± 9 | 0.0005 |
| Gender (M/F) | 51/21 | 32/16 | 0.6282 |
| Atrial fibrillation, n (%) | 27 (38) | 47 (98) | < 0.0001 |
| Paroxysmal AF, n | 23 | 13 | |
| Chronic AF, n | 4 | 34 | |
| Heart rate (bpm) | 69 ± 17 | 71 ± 14 | 0.4098 |
| Hypertension, n (%) | 48 (67) | 40 (83) | 0.0431 |
| Diabetes mellitus, n (%) | 23 (32) | 12 (25) | 0.4123 |
| Hyperlipidemia, n (%) | 38 (53) | 20 (42) | 0.2328 |
| Smoking, n (%) | 38 (53) | 26 (54) | 0.7128 |
| Chronic heart failure, n (%) | 12 (17) | 23 (48) | 0.0002 |
| Previous stroke, n (%) | 8 (11) | 20 (48) | 0.0001 |
| CHA2DS2VASc score | 3.1 ± 1.9 | 4.6 ± 1.4 | < 0.0001 |
| Medications | |||
| Antiplatelet drugs, n (%) | 22 (31) | 20 (42) | 0.2127 |
| Anticoagulants, n (%) | 25 (35) | 29 (60) | 0.0036 |
| Warfarin, n | 20 | 26 | |
| Dabigatran, n | 5 | 3 | |
| Echocardiography | |||
| LAD (mm) | 40 ± 6 | 49 ± 7 | < 0.0001 |
| LVDd (mm) | 49 ± 5 | 49 ± 7 | 0.8570 |
| Simpson LVEF (%) | 62 ± 11 | 60 ± 13 | 0.9258 |
| E/E′ | 11.0 ± 4.4 | 14.0 ± 6.3 | 0.0028 |
| LAVI (mL/m2) | 41 ± 20 | 72 ± 24 | < 0.0001 |
| LAEF (%) | 42.7 ± 15.6 | 19.5 ± 9.4 | < 0.0001 |
| LAWV (cm/s) | 15.6 ± 4.5 | 9.5 ± 3.5 | < 0.0001 |
| LAA eV (cm/s) | 56.4 ± 16.4 | 22.8 ± 15.7 | < 0.0001 |
| LA peak systolic strain | 32.3 ± 13.7 | 12.1 ± 7.2 | < 0.0001 |
| Blood markers | |||
| BNP (pg/mL) | 47.0 (14.1–128) | 211.3 (93.2–414.5) | 0.0274 |
| hs-CRP | 0.090 (0.034–0.285) | 0.190 (0.100–1.670) | 0.0312 |
| D-dimer | 0.87 (0.50–2.16) | 1.28 (0.50–3.61) | 0.4979 |
| FDP | 3.9 (2.6–6.4) | 4.3 (3.0–7.0) | 0.8865 |
| Fibrinogen | 420 ± 95 | 452 ± 115 | 0.1143 |
Abbreviations as in Table 1.
LAD, left atrial dimension; LVDd, left ventricular end-diastolic dimension; LVEF, left ventricular ejection fraction; E/E′, the ratio of the early transmitral flow velocity and the early mitral annular velocity; LAVI, left atrial volume index; LAEF, left atrial emptying fraction, LAWV, left atrial appendage wall velocity, LAA eV, left atrial appendage emptying flow velocity; BNP, brain natriuretic peptide; hs-CRP, high sensitivity C-reactive protein; FDP, fibrinogen degradation products.
Data are expressed as mean ± SD, number (percentage) of subjects or median (interquartile range).
CHA2DS2VASc score before onset of acute ischemic stroke.
Fig. 2Relationship between LA peak systolic strain and LAA eV in all patients. LA peak systolic strain was significantly correlated with LAA eV (R = 0.693, P < 0.0001) (A). Relationship between LA peak systolic strain and LAA eV in patients with sinus rhythm (B), paroxysmal AF (C), or chronic AF (D). LAA, left atrial appendage; eV, LAA emptying flow velocity; AF, atrial fibrillation.
Fig. 3Receiver operating characteristic (ROC) curve analysis of LA peak systolic strain, LAWV, LAVI and septal E/E′ as predictors for LAA dysfunction. The area under the ROC curve for LA peak systolic strain was 0.914. LA peak systolic strain > 19% had a sensitivity of 92% and a specificity of 86%.
Fig. 4The association between CHA2DS2VASc score and the percentages of patients with low peak systolic strain (< 19%).
Fig. 5The associations between LAVI and LA peak systolic strain (A), and LAA eV (B). LAVI, left atrial volume index.*p < 0.05 vs. 1st tertile, †p < 0.05 vs. 2nd tertile.
Fig. 6The association between LA peak systolic strain and LAA dysfunction in patients with (A) high LAWV (≥ 11.5 cm/s) or (B) low LAWV (< 11.5 cm/s). The association between LA peak systolic strain and LAA dysfunction in patients with (C) low LAVI (< 46.9 mL/m2) or (D) high LAVI (≥ 46.9 mL/m2).
Univariate and multivariate logistic regression analyses for LAA dysfunction.
| Variables | Risk ratio | 95% CI | |
|---|---|---|---|
| Age (per 1 year increase) | 1.071 | 1.028–1.121 | 0.0007 |
| Female | 1.063 | 0.464–2.508 | 0.8850 |
| Simpson LVEF (per 1 SD increase) | 0.800 | 0.545–1.166 | 0.2454 |
| E/E′ (per 1 SD increase) | 1.605 | 1.084–2.453 | 0.0219 |
| LAVI (per 1 SD increase) | 4.808 | 2.706–9.231 | < 0.0001 |
| LAEF (per 1 SD increase) | 0.115 | 0.047–0.235 | < 0.0001 |
| LAWV (per 1 SD increase) | 0.123 | 0.051–0.254 | < 0.0001 |
| LA peak systolic strain (per 1 SD increase) | 0.059 | 0.018–0.146 | < 0.0001 |
| Age (per 1 year increase) | 1.002 | 0.924–1.085 | 0.9528 |
| E/E′ (per 1 SD increase) | 1.465 | 0.616–3.010 | 0.4511 |
| LAVI (per 1 SD increase) | 1.279 | 0.636–3.890 | 0.3338 |
| LAWV (per 1 SD increase) | 0.573 | 0.157–1.161 | 0.1007 |
| LA peak systolic strain (per 1 SD increase) | 0.061 | 0.089–0.217 | < 0.0001 |
Abbreviations as in Table 1. CI, confidence interval.